Literature DB >> 4604230

Clinical experience with diamorphine in advanced malignant disease.

R G Twycross.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4604230

Source DB:  PubMed          Journal:  Int J Clin Pharmacol        ISSN: 0300-9718


× No keyword cloud information.
  17 in total

Review 1.  Opioids in chronic pain management: is there a significant risk of addiction?

Authors:  G M Aronoff
Journal:  Curr Rev Pain       Date:  2000

2.  Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.

Authors:  J Hasselström; N Alexander; C Bringel; J O Svensson; J Säwe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Oral narcotic mixtures.

Authors:  E R Hillier
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

4.  Oral narcotic mixtures.

Authors:  D J Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-22

5.  Steady-state kinetics and analgesic effect of oral morphine in cancer patients.

Authors:  J Säwe; B Dahlström; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  An oral buprenorphine and paracetamol combination compared with paracetamol alone: a single dose double-blind postoperative study.

Authors:  R E Bullingham; H J McQuay; R A Moore; L Weir
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

7.  The Brompton mixture versus morphine solution given orally: effects on pain.

Authors:  R Melzack; B M Mount; J M Gordon
Journal:  Can Med Assoc J       Date:  1979-02-17       Impact factor: 8.262

8.  Opioid therapy in patients with a history of substance abuse.

Authors:  Steven D Passik; Kenneth L Kirsh
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Authors:  J Säwe
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

10.  [Intractable cancer pain as a reason for referral : Analysis of pain etiology and previous drug treatment.].

Authors:  S Grond; D Zech; H Dahlmann; S A Schug; B Stobbe; K A Lehmann
Journal:  Schmerz       Date:  1990-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.